Eric Joseph Daniels - 03 Mar 2026 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Chief Development Officer
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Issuer symbol
KPRX
Transactions as of
03 Mar 2026
Net transactions value
$0
Form type
4
Filing time
06 Mar 2026, 14:03:53 UTC
Previous filing
02 Apr 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Daniels Eric Joseph Chief Development Officer C/O KIORA PHARMACEUTICALS, INC., 169 SAXONY RD., SUITE 212, ENCINITAS /s/ Melissa Tosca, Attorney-in-Fact 06 Mar 2026 0001892943

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -238 -0.9% $2.02* 26,137 03 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Net Share settlement, shares withheld for employee tax obligation.